+
Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

What are your goals for visiting NephU?(Required)
How would you like to hear from us?(Required)
Agree(Required)

Archives

Loading Events

4 Part IgAN Experience

4 Part IgAN Experience

1. IgA Nephropathy:  Early Signs and Symptoms, Disease Burden, and Management

During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment needs of IgAN. You will then take a deep dive into the current understanding of IgAN pathogenesis including the four hit cascade and the key role B-cells and APRIL (A PRoliferation-Inducing Ligand) play in driving disease progression.

2. IgAN Simulator

Here you can get an in-depth look at IgAN pathogenesis and the journeys of patients living with IgAN.
  • Pathogenesis: See the origins of IgAN at the molecular level and how that results in its progression
  • Progression: Journey into the profiles of 3 hypothetical patients to see how their IgAN diagnosis was uncovered, and what’s expected in their prognosis

3. Apple Vision Pro Immersive Experience

Experience disease-state education like never before. Using Apple Vision Pro technology, participants can visually explore:
  • The 4-hit pathogenic process of IgAN
  • The role of APRIL in initiating and sustaining kidney injury in IgAN

4. NephU Resource Station

  • Check out our educational infographics and grab printed copies to take with you
  • Learn about our educational tools and treatment summaries

Location

Aberdeen Barn Steakhouse

5805 Northampton Blvd
Virginia Beach, VA 23455 United States
+ Google Map
7574641580 View Venue Website

Featuring

Kimberly Means

Kimberly Means, PharmD, BCCCP, BSN, RN

Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Kimberly Means, PharmD, BCCCP, BSN, RN, is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).  Dr Means earned her B.S. in Nursing (BSN) and her Doctor of Pharmacy (PharmD) from Virginia Commonwealth University (VCU) in Richmond, Virginia.  She completed a PGY-1 Pharmacy Practice Residency and a PGY-2 Critical Care Residency at VCU Health in Richmond, Virginia.  Prior to joining Otsuka, she worked as a critical care nurse at VCU Health, a Critical Care Clinical Pharmacist at Henrico Doctors’ Hospital, and a Clinical Pharmacist in Surgical Services at VCU Health.  During her time as a Clinical Assistant Professor at the VCU School of Pharmacy and VCU Health she served as a preceptor for pharmacy students and pharmacy residents.  Dr Means is a Board Certified Critical Care Pharmacotherapy Specialist (BCCCP).

Michael Filsinger

Michael Filsinger, MPA, PA-C

Nephrology Medical Science Liaison

Otsuka Pharmaceutical Development & Commercialization, Inc.*

Michael Filsinger, MPA, PA-C is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael earned his Bachelor of Health Care Sciences as well as Master of Physician Assistant at Duquesne University in Pittsburgh, PA. Following his graduate training, Michael went on to complete a Pediatric Surgery Residency at Children’s National Medical Center in Washington, DC Prior to joining Otsuka, Michael spent the last 15 years working in solid organ transplant in Charlotte, NC where he developed a passion for improving the care of patients with renal disease and ESKD.

Kimberly Means, PharmD, BCCCP, BSN, RN and Michael Filsinger, MPA, PA-C are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Join Today for Instant Access to all NephU Offerings.

Membership is free!

Join NephU today at no cost to register for this event and access to other premium content.

  • The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
  • Quickly learn more about the topics that interest you.
  • Access our library of on-demand kidney health resources
  • Gain key insights from industry experts & though leaders.